Selected research
Market Structure
Global Human Blood Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Human Blood Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Human Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Human Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Human Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Human Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Human Blood Products include Biotest, BPL, CSL, Grifols, Kedrion, KM Biologics, LFB Group, Octapharma and Boya Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Human Blood Products market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Human Blood Products and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Human Blood Products revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Human Blood Products market size, projected growth trends, production technologies, key applications, and end-use industries.
Human Blood Products Segment by Company
Biotest
BPL
CSL
Grifols
Kedrion
KM Biologics
LFB Group
Octapharma
Boya Bio
Hualan Bio
Nanyue Bio
RAAS
Shuanglin Bio
CBPO
Tiantan Bio
Weiguang Bio
Takeda
Yuanda Shuyang
Human Blood Products Segment by Type
Immune Globulin
Coagulation Factor
Albumin
Other
Human Blood Products Segment by Application
Hospital
Retail Pharmacy
Other
Human Blood Products Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Blood Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Human Blood Products in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human Blood Products industry.
Chapter 3: Detailed analysis of Human Blood Products companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Blood Productsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Immune Globulin
- Coagulation Factor
- Albumin
- Other
Applications
- Hospital
- Retail Pharmacy
- Other
Companies covered
- Biotest
- BPL
- CSL
- Grifols
- Kedrion
- KM Biologics
- LFB Group
- Octapharma
- Boya Bio
- Hualan Bio
- Nanyue Bio
- RAAS
- Shuanglin Bio
- CBPO
- Tiantan Bio
- Weiguang Bio
- Takeda
- Yuanda Shuyang
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Human Blood Products Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Immune Globulin
- 1.2.3 Coagulation Factor
- 1.2.4 Albumin
- 1.2.5 Other
- 1.3 Market Analysis by Application
- 1.3.1 Global Human Blood Products Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Retail Pharmacy
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Human Blood Products Growth Trends by Region
- 1.5.1 Global Human Blood Products Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Human Blood Products Market Size by Region (2021-2026)
- 1.5.3 Human Blood Products Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Human Blood Products Market Dynamics
- 2.1 Human Blood Products Industry Trends
- 2.2 Human Blood Products Industry Drivers
- 2.3 Human Blood Products Industry Opportunities and Challenges
- 2.4 Human Blood Products Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Human Blood Products Revenue by Company (2021-2026)
- 3.2 Global Human Blood Products Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Human Blood Products Key Company Head office and Area Served
- 3.4 Global Human Blood Products Company, Product Type & Application
- 3.5 Global Human Blood Products Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Human Blood Products Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Human Blood Products Players Market Share by Revenue in 2025
- 3.6.3 2025 Human Blood Products Tier 1, Tier 2, and Tier 3
4 Human Blood Products Market by Type
- 4.1 Global Human Blood Products Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Human Blood Products Market Size by Type (2021-2032)
- 4.3 Global Human Blood Products Market Size Share by Type (2021-2032)
5 Human Blood Products Market by Application
- 5.1 Global Human Blood Products Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Human Blood Products Market Size by Application (2021-2032)
- 5.3 Global Human Blood Products Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Biotest
- 6.1.1 Biotest Company Information
- 6.1.2 Biotest Business Overview
- 6.1.3 Biotest Human Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Biotest Human Blood Products Product Portfolio
- 6.1.5 Biotest Recent Developments
- 6.2 BPL
- 6.2.1 BPL Company Information
- 6.2.2 BPL Business Overview
- 6.2.3 BPL Human Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 BPL Human Blood Products Product Portfolio
- 6.2.5 BPL Recent Developments
- 6.3 CSL
- 6.3.1 CSL Company Information
- 6.3.2 CSL Business Overview
- 6.3.3 CSL Human Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 CSL Human Blood Products Product Portfolio
- 6.3.5 CSL Recent Developments
- 6.4 Grifols
- 6.4.1 Grifols Company Information
- 6.4.2 Grifols Business Overview
- 6.4.3 Grifols Human Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Grifols Human Blood Products Product Portfolio
- 6.4.5 Grifols Recent Developments
- 6.5 Kedrion
- 6.5.1 Kedrion Company Information
- 6.5.2 Kedrion Business Overview
- 6.5.3 Kedrion Human Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Kedrion Human Blood Products Product Portfolio
- 6.5.5 Kedrion Recent Developments
- 6.6 KM Biologics
- 6.6.1 KM Biologics Company Information
- 6.6.2 KM Biologics Business Overview
- 6.6.3 KM Biologics Human Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 KM Biologics Human Blood Products Product Portfolio
- 6.6.5 KM Biologics Recent Developments
- 6.7 LFB Group
- 6.7.1 LFB Group Company Information
- 6.7.2 LFB Group Business Overview
- 6.7.3 LFB Group Human Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 LFB Group Human Blood Products Product Portfolio
- 6.7.5 LFB Group Recent Developments
- 6.8 Octapharma
- 6.8.1 Octapharma Company Information
- 6.8.2 Octapharma Business Overview
- 6.8.3 Octapharma Human Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Octapharma Human Blood Products Product Portfolio
- 6.8.5 Octapharma Recent Developments
- 6.9 Boya Bio
- 6.9.1 Boya Bio Company Information
- 6.9.2 Boya Bio Business Overview
- 6.9.3 Boya Bio Human Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Boya Bio Human Blood Products Product Portfolio
- 6.9.5 Boya Bio Recent Developments
- 6.10 Hualan Bio
- 6.10.1 Hualan Bio Company Information
- 6.10.2 Hualan Bio Business Overview
- 6.10.3 Hualan Bio Human Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Hualan Bio Human Blood Products Product Portfolio
- 6.10.5 Hualan Bio Recent Developments
- 6.11 Nanyue Bio
- 6.11.1 Nanyue Bio Company Information
- 6.11.2 Nanyue Bio Business Overview
- 6.11.3 Nanyue Bio Human Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Nanyue Bio Human Blood Products Product Portfolio
- 6.11.5 Nanyue Bio Recent Developments
- 6.12 RAAS
- 6.12.1 RAAS Company Information
- 6.12.2 RAAS Business Overview
- 6.12.3 RAAS Human Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 RAAS Human Blood Products Product Portfolio
- 6.12.5 RAAS Recent Developments
- 6.13 Shuanglin Bio
- 6.13.1 Shuanglin Bio Company Information
- 6.13.2 Shuanglin Bio Business Overview
- 6.13.3 Shuanglin Bio Human Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Shuanglin Bio Human Blood Products Product Portfolio
- 6.13.5 Shuanglin Bio Recent Developments
- 6.14 CBPO
- 6.14.1 CBPO Company Information
- 6.14.2 CBPO Business Overview
- 6.14.3 CBPO Human Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 CBPO Human Blood Products Product Portfolio
- 6.14.5 CBPO Recent Developments
- 6.15 Tiantan Bio
- 6.15.1 Tiantan Bio Company Information
- 6.15.2 Tiantan Bio Business Overview
- 6.15.3 Tiantan Bio Human Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Tiantan Bio Human Blood Products Product Portfolio
- 6.15.5 Tiantan Bio Recent Developments
- 6.16 Weiguang Bio
- 6.16.1 Weiguang Bio Company Information
- 6.16.2 Weiguang Bio Business Overview
- 6.16.3 Weiguang Bio Human Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Weiguang Bio Human Blood Products Product Portfolio
- 6.16.5 Weiguang Bio Recent Developments
- 6.17 Takeda
- 6.17.1 Takeda Company Information
- 6.17.2 Takeda Business Overview
- 6.17.3 Takeda Human Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Takeda Human Blood Products Product Portfolio
- 6.17.5 Takeda Recent Developments
- 6.18 Yuanda Shuyang
- 6.18.1 Yuanda Shuyang Company Information
- 6.18.2 Yuanda Shuyang Business Overview
- 6.18.3 Yuanda Shuyang Human Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Yuanda Shuyang Human Blood Products Product Portfolio
- 6.18.5 Yuanda Shuyang Recent Developments
7 North America
- 7.1 North America Human Blood Products Market Size (2021-2032)
- 7.2 North America Human Blood Products Market Size by Type
- 7.2.1 North America Human Blood Products Market Size by Type (2021-2026)
- 7.2.2 North America Human Blood Products Market Size by Type (2027-2032)
- 7.2.3 North America Human Blood Products Market Share by Type (2021-2032)
- 7.3 North America Human Blood Products Market Size by Application
- 7.3.1 North America Human Blood Products Market Size by Application (2021-2026)
- 7.3.2 North America Human Blood Products Market Size by Application (2027-2032)
- 7.3.3 North America Human Blood Products Market Share by Application (2021-2032)
- 7.4 North America Human Blood Products Market Size by Country
- 7.4.1 North America Human Blood Products Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Human Blood Products Market Size by Country (2021-2026)
- 7.4.3 North America Human Blood Products Market Size by Country (2027-2032)
- 7.4.4 North America Human Blood Products Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Human Blood Products Market Size (2021-2032)
- 8.2 Europe Human Blood Products Market Size by Type
- 8.2.1 Europe Human Blood Products Market Size by Type (2021-2026)
- 8.2.2 Europe Human Blood Products Market Size by Type (2027-2032)
- 8.2.3 Europe Human Blood Products Market Share by Type (2021-2032)
- 8.3 Europe Human Blood Products Market Size by Application
- 8.3.1 Europe Human Blood Products Market Size by Application (2021-2026)
- 8.3.2 Europe Human Blood Products Market Size by Application (2027-2032)
- 8.3.3 Europe Human Blood Products Market Share by Application (2021-2032)
- 8.4 Europe Human Blood Products Market Size by Country
- 8.4.1 Europe Human Blood Products Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Human Blood Products Market Size by Country (2021-2026)
- 8.4.3 Europe Human Blood Products Market Size by Country (2027-2032)
- 8.4.4 Europe Human Blood Products Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Human Blood Products Market Size (2021-2032)
- 9.2 China Human Blood Products Market Size by Type
- 9.2.1 China Human Blood Products Market Size by Type (2021-2026)
- 9.2.2 China Human Blood Products Market Size by Type (2027-2032)
- 9.2.3 China Human Blood Products Market Share by Type (2021-2032)
- 9.3 China Human Blood Products Market Size by Application
- 9.3.1 China Human Blood Products Market Size by Application (2021-2026)
- 9.3.2 China Human Blood Products Market Size by Application (2027-2032)
- 9.3.3 China Human Blood Products Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Human Blood Products Market Size (2021-2032)
- 10.2 Asia Human Blood Products Market Size by Type
- 10.2.1 Asia Human Blood Products Market Size by Type (2021-2026)
- 10.2.2 Asia Human Blood Products Market Size by Type (2027-2032)
- 10.2.3 Asia Human Blood Products Market Share by Type (2021-2032)
- 10.3 Asia Human Blood Products Market Size by Application
- 10.3.1 Asia Human Blood Products Market Size by Application (2021-2026)
- 10.3.2 Asia Human Blood Products Market Size by Application (2027-2032)
- 10.3.3 Asia Human Blood Products Market Share by Application (2021-2032)
- 10.4 Asia Human Blood Products Market Size by Country
- 10.4.1 Asia Human Blood Products Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Human Blood Products Market Size by Country (2021-2026)
- 10.4.3 Asia Human Blood Products Market Size by Country (2027-2032)
- 10.4.4 Asia Human Blood Products Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Human Blood Products Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Human Blood Products Market Size by Type
- 11.2.1 South America, Middle East & Africa Human Blood Products Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Human Blood Products Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Human Blood Products Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Human Blood Products Market Size by Application
- 11.3.1 South America, Middle East & Africa Human Blood Products Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Human Blood Products Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Human Blood Products Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Human Blood Products Market Size by Country
- 11.4.1 South America, Middle East & Africa Human Blood Products Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Human Blood Products Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Human Blood Products Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Human Blood Products Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst